Check out our interview with co-founders and . They have attended CES and ViVe as part of our international Pre-Seed Funding tour, where they showcased their groundbreaking innovation on the world stage!
What motivated you to start Vope Medical?
Vope Medical started as a project in the surgical innovation program at 不良研究所. After interviewing 30 surgeons, we found that visibility during surgeries and lens cleaning was problematic with no software solutions on the market. Augmented images were proposed to surgeons who seemed open at the time. Since then, we鈥檝e only been growing.
How did the Dobson Centre play a role in Vope Medical as we know it today?
Beyond the great people and hospitality, the Dobson provides great support at every stage and is tailored to each industry. We won 2nd place in the Dobson Cup, and the funding at an early-stage made a difference for Vope. Returning to the Dobson at the fundraising stage has been instrumental in connecting us with key partners and investors.
What are the unique challenges that you face as a medtech start-up?
Medical devices cannot generate revenue until the FDA and HC process. However, to get to these stages and apply for regulatory approval, you need funding. Being a start-up in medtech has more risk and investment but ultimately, as founders we learn how to surround ourselves with the right partners and mentors that will help us get there. In Quebec, we are lucky to also have a lot of support when it comes to mitigating the risks of the regulatory process.
About Vope Medical
AI-augmented clear surgical visualization. Our software delivers clear vision in endoscopic surgery to reduce surgical errors and improve operational efficiency. We are addressing a significant unmet need for clear vision in endoscopic surgery where 37% of the total time in surgery, the view of the surgical site is obstructed from blood or fog contamination on the camera. Our software enhances surgical view in real-time using an AI-driven approach. We provide seamless endoscopic system integration - agnostic to all optics systems on the market.
